Ethiopia commemorated World TB Day 2026 from 27–29 March through a three-day national event that brought together government leaders, researchers, partners, civil society, and TB-affected communities to accelerate action against tuberculosis (TB). The observance, held under the theme “Yes! We Can End TB: Led by countries, powered by people,” included the National Tuberculosis Research Conference organized by the Oromia Regional Health Bureau in collaboration with the Ethiopian Public Health Institute.
The first two days focused on research presentations, knowledge sharing, and recognition of outstanding contributions to TB control over the past 25 years through the TB Research Advisory Council (TRAC). Dr Dereje Duguma, State Minister of Health, reaffirmed Ethiopia’s commitment to ending TB as a public health priority, emphasizing domestic financing, expanded access to quality services, and leveraging innovation and digital solutions. Regional and national leaders highlighted the importance of reaching every community, reducing stigma, strengthening surveillance, and translating research into actionable programs.
The World Health Organization (WHO) Ethiopia actively participated, moderating sessions on TB research, elimination strategies, vaccine development, and translating evidence into policy. Dr Francis Kasolo, WHO Representative to Ethiopia, underscored the need for sustained collaboration, investment, innovation, multisectoral action, patient-centered care, and resilient health systems.
The event concluded with an official commemoration in Sululta town, Sheger City, bringing together senior officials, development partners, civil society, and TB-affected communities. Participants included politicians, health advisors, TB ambassadors, and representatives from partner organizations. Survivor testimonies highlighted ongoing challenges, such as stigma, delayed care-seeking, and access barriers, while showcasing the benefits of expanded treatment, particularly for drug-resistant TB. TRAC awards recognized individuals and institutions for their contributions, and a Lifetime Achievement Award honored Dr Fekadeselassie Mikru for decades of leadership in Ethiopia’s TB response.
Despite significant progress, TB remains a major public health challenge in Ethiopia, with an estimated 186,000 new cases annually and around 2,500 drug-resistant TB cases each year. Studies indicate that approximately 53% of TB-affected households face catastrophic costs. Ethiopia continues to scale up WHO-recommended tools, including rapid molecular diagnostics, shorter treatment regimens, and AI-powered digital X-ray technologies. Tuberculosis is preventable and curable, yet it disproportionately affects vulnerable populations. WHO reaffirmed its commitment to supporting Ethiopia in accelerating efforts toward TB elimination.
